Recursion Pharmaceuticals Stock Tumbles to 52Week Low Amid Market Pressures US GDP Growth Revised Lower for First Quarter Economic Expansion Slows Three Signs from APEC That US and China Remain Far Apart on Trade Treasury Yield Surge Prompts Bond Investors to Seek Alternative FixedIncome Opportunities Uncertainty and Caution in Tech Employment Data CompTIA Analysis Reveals GLP1 Weight Loss Drugs Driving Up Prescription Costs CoPays Expected to Rise DERM Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Shares Decline BFLY Q1 2026 Earnings EPS Beat Surprises as Butterfly Network Posts Narrower Loss Voyager Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response JBHT Q1 2026 Earnings EPS Beats Estimates as Operational Efficiency Drives Performance Teck Resources Q1 2026 Earnings EPS Beats Estimates by Over 53 Despite Modest Market Pullback GM Q1 2026 Earnings Blowout EPS Surprise Drives Shares Higher Pacific Biosciences PACB Edges Higher But Key Resistance Remains a Hurdle GSUN Rebounds From Support Golden Sun Technology Group Gains 325 Corvus Pharmaceuticals CRVS Rallies 174 Technical Breakout or Consolidation Amphastar Pharmaceuticals AMPH Gains 138 as Stock Consolidates Near Key Resistance Mount Logan Capital Notes MLCIL Hold Steady at 2295 No Momentum as Key Levels Firm Chinas Push for Humanoid Robot Workforce Raises Competitive Stakes INVX Q1 2026 Earnings EPS Surges 1015 Above Estimates Revenue Not Disclosed Stock Declines 25 Sypris Solutions SYPR Surges Over 6 Testing Key Resistance at 348